Radio-frequency Ablation in Knee Osteoarthritis by Three Needles Technique

August 1, 2018 updated by: Alaa Fouli Gaber Ebrahim

Three Needles Approach... A New Technique of Genicular Nerve Radio-frequency Ablation for Pain Relief in Advanced Knee Osteoarthritis

The study is designed to evaluate and compare the efficacy of three needles approach as a new technique in radiofrequency neurotomy of genicular nerve versus the traditional single needle approach as a treatment of advanced knee osteoarthritic pain. Primary outcome:

  1. Pain intensity via the visual analogue score (VAS).
  2. Function and pain via the Oxford Knee Score. Evaluated after 6 months of the procedure

Secondary outcome:

  1. Failure rate.
  2. Incidence of any complication.
  3. Total analgesic requirement during the period of follow up.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Minya, Egypt, 61111
        • Faculty of Medicine, Minia University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

33 years to 83 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1- Age 35-85 years old 2- Patients with stage 3 or higher OA-related radiological changes based on Kellgren-Lawrence (K/L) rating scale 3- Knee pain for at least 3 months 4-Patients are clinically unresponsive to conservative treatment modalities (physical therapy and rehabilitation practices, orally administered analgesics and anti-inflammatory drugs).

Exclusion Criteria:

  • 1- Patients with other causes of pain as radiculopathy, neurological disorders or intermittent claudication. 2- Previous knee trauma. 3- Previous knee surgery. 4- Patients received intra-articular injection during the previous three months.

    5- Acute knee pain. 6- Crystal arthropathy. 7- Joint effusion. 8- Serious neurological or psychiatric disorders. 9- On anticoagulant medication. 10- Any other connective tissue disorder that affects the knee joint. 11- skin infection at the site of injection. 12-patient refusal.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Three needles group
Ablation of the genicular nerves for pain relief in advanced knee osteoarthritis
Active Comparator: Single needle group
Ablation of the genicular nerves for pain relief in advanced knee osteoarthritis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analogue score
Time Frame: 6 months after the procedure
Pain intensity via the visual analogue score (VAS).
6 months after the procedure
Oxford knee score
Time Frame: 6 months after the procedure
Follow up of pain and function via the Oxford knee score
6 months after the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Failure rate
Time Frame: 6 months after the procedure
Persistence of pain after the procedure
6 months after the procedure
Incidence of complication
Time Frame: 6 months after the procedure
Any infection, heamatoma
6 months after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Omyma Sh Mohamed, Ass. prof., Minia University
  • Study Chair: And El raheem Ma Mohamed, Lecturer, Assist university
  • Study Chair: Sarah Mo Omar, Lecturer, Minia University
  • Principal Investigator: Alaa Fo Gaber, Resident, Minia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2018

Primary Completion (Anticipated)

August 1, 2018

Study Completion (Anticipated)

November 1, 2018

Study Registration Dates

First Submitted

July 18, 2018

First Submitted That Met QC Criteria

August 1, 2018

First Posted (Actual)

August 3, 2018

Study Record Updates

Last Update Posted (Actual)

August 3, 2018

Last Update Submitted That Met QC Criteria

August 1, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Radio-frequency ablation of genicular nerves

3
Subscribe